Microbiological efficacy of levofloxacin for treatment of community- acquired pneumonia due to Chlamydia pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 5, 2000, Pages 1409-

  Hammerschlag, M R ^a   Roblin, P M ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANTIBACTERIAL ACTIVITY; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DRUG EFFICACY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, BACTERIAL;

EID: 0034052859     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.5.1409-1409.2000     Document Type: Letter

References (6)